FAKTOR OPTIONSSCHEIN - MERCK & CO. | Market Closed - BOERSE MUENCHEN 19:26:39 31/05/2024 BST | ||
| 9.1 EUR | -8.63% |
|
| 1 month | -19.75% | ||
| 3 months | -19.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 9.1 | -8.63% |
| 30/05/24 | 9.96 | +5.96% |
| 29/05/24 | 9.4 | -0.84% |
| 28/05/24 | 9.48 | -12.55% |
| 27/05/24 | 10.84 | -1.09% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 07:26 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GX39WC |
| ISIN | DE000GX39WC2 |
| Date issued | 05/11/2021 |
| Strike | 99.62 $ |
| Maturity | Unlimited |
| Parity | 2.6 : 1 |
| Emission price | 10.07 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.75 € |
|---|---|
| Lowest since issue | 2.38 € |
| Spread | 0.03 € |
| Spread % | 0.33% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Certificates
- Certificat